Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis

Liver International

Volumn 31, Issue 7, 2011, Pages 1013-1020

  Fujiwara, Keiichi ^a   Yasui, Shin ^a   Tawada, Akinobu ^a   Fukuda, Yoshihiro ^a   Nakano, Masayuki ^b   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tokyo Women s Medical University   (Japan)

Author keywords

Autoimmune hepatitis; Fulminant hepatitis; Liver histology; Scoring system; Severe hepatitis

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G;

ACUTE HEPATITIS; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANTIBODIES, ANTINUCLEAR; BILIRUBIN; BIOLOGICAL MARKERS; FEMALE; HEPATITIS, AUTOIMMUNE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LIVER; MALE; MICROSOMES, LIVER; MIDDLE AGED; RESEARCH DESIGN; SEROLOGIC TESTS;

EID: 79960096265     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02524.x     Document Type: Article

References (25)

1. Czaja AJ. Autoimmune hepatitis: evolving concepts and treatment strategies. Dig Dis Sci 1995; 40: 435-56.
2. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993; 105: 1824-32.
3. Fujiwara K, Mochida S, et al. Intractable Liver Diseases Study Group of Japan. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res 2008; 38: 646-57.
4. Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl 2008; 14: S67-79.
5. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology 2008; 47: 1401-15.
6. Fujiwara K, Yasui S, Tawada A, et al. Autoimmune fulminant liver failure in adults. Experience in a Japanese center. Hepatol Res 2011; 41: 133-41.
7. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
8. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
9. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified diagnostic criteria for autoimmune hepatitis. Hepatology 2008; 48: 169-76.
10. Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute onset autoimmune hepatitis. J Gastroenterol 2008; 43: 951-8.
11. Yasui S, Fujiwara K, Yonemitsu Y, et al. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011; 43: 378-90.
12. Fujiwara K, Nakano M, Yasui S, et al. Advanced histology and impaired liver regeneration are associated with disease severity in acute onset autoimmune hepatitis. Histopathology 2011; 58: 693-704.
13. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
14. Kamath PS, Kim WR. The model of end-stage liver disease (MELD). Hepatology 2007; 45: 797-805.
15. Dienes HP. Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity. Veroff Pathol 1989; 132: 1-107.
16. Meyer zum Büschenfelde KH, Dienes HP. Autoimmune hepatitis. Definition-classification-histopathology-immunopathogenesis. Virchows Arch 1996; 429: 1-12.
17. Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994; 21: 866-71.
18. Kaymakoglu S, Cakaloglu Y, Demir K, et al. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 1998; 28: 78-83.
19. Potthoff A, Deterding K, Trautwein C, et al. Steroid treatment for severe acute cryptogenic hepatitis. Z Gastroenterol 2007; 45: 15-9.
20. Bernal W, Ma Y, Smith HM, et al. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007; 47: 664-70.
21. Tokumoto Y, Onji M. Acute-onset autoimmune hepatitis. Intern Med 2007; 46: 1-2.
22. Singh R, Nair S, Farr G, Mason A, Perrillo R. Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol 2002; 97: 2670-3.
23. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008; 48: 1540-8.
24. Yeoman AD, Westbrook RH, Al-Chalabi T, et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009; 50: 538-45.
25. Miyake Y, Iwasaki Y, Kobashi H, et al. Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group. Dig Liver Dis 2010; 42: 210-5.